Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
暂无分享,去创建一个
[1] Alexander V Kabanov,et al. Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.
[2] M. Bergeron,et al. Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1. , 2000, Biochimica et biophysica acta.
[3] C Alexiou,et al. Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.
[4] M. Simionescu,et al. Designing of ‘intelligent’ liposomes for efficient delivery of drugs , 2002, Journal of cellular and molecular medicine.
[5] Vladimir P. Torchilin,et al. Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[6] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[7] Marie-Hélène Dufresne,et al. Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[8] J M Wilkinson,et al. Nanotechnology applications in medicine. , 2003, Medical device technology.
[9] Giuseppe Altavilla,et al. DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination. , 2006, Vaccine.
[10] T. Mccarthy,et al. Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention. , 2005, Molecular pharmaceutics.
[11] M. Bednarski,et al. Tumor Regression by Targeted Gene Delivery to the Neovasculature , 2002, Science.
[12] Y. Cai,et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[13] N. Nishiyama,et al. Differential gene expression profile between PC-14 cells treated with free cisplatin and cisplatin-incorporated polymeric micelles. , 2003, Bioconjugate chemistry.
[14] D. Markovitz,et al. The role of mononuclear phagocytes in HTLV-III/LAV infection. , 1986, Science.
[15] L. Tiefenauer,et al. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. , 1993, Bioconjugate chemistry.
[16] F M Muggia,et al. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] R. J. Lee,et al. Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.
[18] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[19] Yechezkel Barenholz,et al. Pharmacokinetics of Pegylated Liposomal Doxorubicin , 2003, Clinical pharmacokinetics.
[20] Jean-Marie Devoisselle,et al. Magnetic nanoparticles and their applications in medicine. , 2006, Nanomedicine.
[21] R. Jain. Delivery of molecular and cellular medicine to solid tumors. , 2001, Advanced drug delivery reviews.
[22] J. Kreuter,et al. Nanoparticulate systems for brain delivery of drugs. , 2001 .
[23] V. Torchilin. Targeted pharmaceutical nanocarriers for cancer therapy and imaging , 2007, The AAPS Journal.
[24] M. S. Muthu,et al. Preparation and characterization of nanoparticles containing an atypical antipsychotic agent. , 2007, Nanomedicine.
[25] H. Fessi,et al. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. , 2005, Critical reviews in therapeutic drug carrier systems.
[26] Jinming Gao,et al. Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells , 2008 .
[27] Robert J. Levy,et al. Nanoparticle drug delivery system for restenosis , 1997 .
[28] Thommey P. Thomas,et al. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. , 2006, Biomacromolecules.
[29] Hari Singh Nalwa,et al. Nanotechnology and health safety--toxicity and risk assessments of nanostructured materials on human health. , 2007, Journal of nanoscience and nanotechnology.
[30] M. Swartz,et al. The physiology of the lymphatic system. , 2001, Advanced drug delivery reviews.
[31] P. Couvreur,et al. Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles , 1992, Investigational New Drugs.
[32] R. Gurny,et al. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles. , 2007, International journal of pharmaceutics.
[33] S. B. Tiwari,et al. A review of nanocarrier-based CNS delivery systems. , 2006, Current drug delivery.
[34] Robert Gurny,et al. Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .
[35] J. Xue,et al. Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles. , 2007, Biomaterials.
[36] Hongzhe Sun,et al. Transferrin-mediated gold nanoparticle cellular uptake. , 2005, Bioconjugate chemistry.
[37] J. Kreuter. Nanoparticles--a historical perspective. , 2007, International journal of pharmaceutics.
[38] N. K. Jain,et al. Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[39] S. Zalipsky. Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. , 1995, Bioconjugate chemistry.
[40] V. Venkateswarlu,et al. Novel delivery systems for drug targeting to the brain , 2004 .
[41] H. Benson,et al. Drug delivery across the blood-brain barrier. , 2004, Current drug delivery.
[42] V. Torchilin,et al. Micellar Nanocarriers: Pharmaceutical Perspectives , 2006, Pharmaceutical Research.
[43] D. Begley. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. , 2004, Pharmacology & therapeutics.
[44] Hua Ai,et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. , 2006, Nano letters.
[45] Miklós Tóth,et al. Animal Models of Complement-Mediated Hypersensitivity Reactions to Liposomes and Other Lipid-Based Nanoparticles , 2007, Journal of liposome research.
[46] Daniel G. Anderson,et al. Biodegradable polymeric vectors for gene delivery to human endothelial cells. , 2006, Bioconjugate chemistry.
[47] A. C. Hunter,et al. Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] C. Murphy,et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.
[49] K. Mäder,et al. Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.
[50] M. Roco. Nanotechnology: convergence with modern biology and medicine. , 2003, Current opinion in biotechnology.
[51] Robert Langer,et al. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. , 2007, Nanomedicine.
[52] M. S. Muthu,et al. Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. , 2008, Nanomedicine.
[53] M. Ricci,et al. Solid lipid nanoparticles for targeted brain drug delivery. , 2007, Advanced drug delivery reviews.
[54] D. Lasič. Novel applications of liposomes. , 1998, Trends in biotechnology.
[55] D. Maysinger,et al. Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles , 2003, Science.
[56] C. Schengrund,et al. Dendrimers and antivirals: a review. , 2005, Current drug targets. Infectious disorders.
[57] S. Moghimi,et al. Cellular Distribution of Nonionic Micelles , 2004, Science.
[58] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[59] Anna Moore,et al. In vivo imaging of siRNA delivery and silencing in tumors , 2007, Nature Medicine.
[60] Thommey P. Thomas,et al. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. , 2006, Bioconjugate chemistry.
[61] F. Calon,et al. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. , 2003, Human gene therapy.
[62] K. Neoh,et al. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. , 2006, Biomaterials.
[63] Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting , 2008 .
[64] P. Couvreur,et al. Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.
[65] T. Xu,et al. Design, synthesis and potent pharmaceutical applications of glycodendrimers: a mini review. , 2007, Current drug discovery technologies.
[66] K. Strebhardt,et al. Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. , 2006, Biomaterials.
[67] T. Stinchcombe,et al. Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel. , 2007, Nanomedicine.
[68] R. Cavalli,et al. Intravenous Administration to Rabbits of Non-stealth and Stealth Doxorubicin-loaded Solid Lipid Nanoparticles at Increasing Concentrations of Stealth Agent: Pharmacokinetics and Distribution of Doxorubicin in Brain and Other Tissues , 2002, Journal of drug targeting.
[69] John W. Park,et al. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. , 1997, Biochemistry.
[70] Y. Kuo,et al. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. , 2007, International journal of pharmaceutics.
[71] M. Bally,et al. Preparation, characterization, and biological analysis of liposomal formulations of vincristine. , 2005, Methods in enzymology.
[72] M. Sastry,et al. Gold nanoparticles as carriers for efficient transmucosal insulin delivery. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[73] Erkki Ruoslahti,et al. Organ targeting In vivo using phage display peptide libraries , 1996, Nature.
[74] Lisa Brannon-Peppas,et al. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery , 1995 .
[75] Seungpyo Hong,et al. The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .
[76] J. Feijen,et al. The effect of phagocytosis of poly(L-lactic acid) fragments on cellular morphology and viability. , 1993, Journal of biomedical materials research.
[77] Russell J Mumper,et al. Brain uptake of thiamine-coated nanoparticles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[78] W. Mark Saltzman,et al. Nanosystems for simultaneous imaging and drug delivery to T cells , 2007, The AAPS Journal.
[79] Rubiana M Mainardes,et al. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. , 2005, International journal of pharmaceutics.
[80] V. Rotello,et al. Stability of Gold Nanoparticle‐Bound DNA toward Biological, Physical, and Chemical Agents , 2006, Chemical biology & drug design.
[81] M. Grinstaff,et al. Therapeutic and diagnostic applications of dendrimers for cancer treatment. , 2008, Advanced drug delivery reviews.
[82] M. Bergeron,et al. Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes. , 2002, Biochimica et biophysica acta.
[83] M. Baccarani,et al. Liposomal daunorubicin (DaunoXome) for treatment of relapsed meningeal acute myeloid leukemia , 2002, Leukemia.
[84] Afsaneh Lavasanifar,et al. Amphiphilic block copolymers for drug delivery. , 2003, Journal of pharmaceutical sciences.
[85] R. Costo,et al. The preparation of magnetic nanoparticles for applications in biomedicine , 2003 .
[86] V. Venkateswarlu,et al. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[87] M. Samanta,et al. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease , 2008, Brain Research.
[88] Theresa M Allen,et al. Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. , 2002, Cancer research.
[89] Erkki Ruoslahti,et al. αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.
[90] Xiao-bing Xiong,et al. Polymeric micelles for drug targeting , 2007, Journal of drug targeting.